Janux Therapeutics, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
JANX Company Description
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.
JANX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view JANX Smart Score
Score Breakdown
JANX Company Description
Show More
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of JANX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by JANX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of JANX in WallStreetBets Daily Discussion
JANX News
Recent insights relating to JANX
CNBC Recommendations
Recent picks made for JANX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in JANX
Corporate Flights
Flights by private jets registered to JANX
Our Analysis